NCT00646581View on ClinicalTrials.gov

Effect of Single Dose Intranasal Insulin On Cognitive Function

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

Placebo

Placebo

DRUG

Insulin (Humulin)

40 IU Intranasal Insulin will be administered once

Trial Locations (1)

02114

Freedom Trail Clinic, Boston

All Listed Sponsors
lead

University of Massachusetts, Worcester

OTHER

NCT00646581 - Effect of Single Dose Intranasal Insulin On Cognitive Function | Biotech Hunter | Biotech Hunter